24×7 Emergency Care

1-8-31/1, Minister Road, Secunderabad, Telangana 500003

EMERGENCY:Fever + extreme muscle rigidity + confusion in a patient on antipsychotics or metoclopramide —call040-46324365immediately — 24 hours, 7 days— 24/7

AUTONOMIC NERVOUS SYSTEM DISORDERS

Neuroleptic Malignant Syndrome — Emergency Diagnosis and ICU Management at KIMS Hyderabad

Q: My son is on haloperidol for schizophrenia and has developed a high fever and his muscles are extremely stiff. His psychiatrist is not available. What should I do right now?

Call 040-46324365 immediately and bring him to the KIMS emergency department. Do not wait for the psychiatrist. High fever with extreme muscle stiffness in a patient on haloperidol must be urgently evaluated for Neuroleptic Malignant Syndrome and other possible causes — a neurological and medical emergency. While waiting for the ambulance: do not give any additional medications · Keep him cool (fan, cool water on skin, air conditioning) · Give sips of water if he is conscious and can swallow. At KIMS, the emergency team will stop the haloperidol, check serum CK and renal function, start IV dantrolene, begin aggressive cooling, and admit to the ICU. Time from recognition to treatment is the most important factor in survival. Call 040-46324365 now.

Q: My mother is not on antipsychotics. She is on metoclopramide for nausea after surgery. She has now developed fever, stiffness, and confusion. Can metoclopramide cause NMS?

Yes — metoclopramide (the commonly used antiemetic Perinorm or Reglan) is a dopamine D2 receptor antagonist and is a recognised though underappreciated cause of NMS. This is one of the most important points about NMS in India — it is not exclusively a reaction to antipsychotic drugs. Any dopamine-blocking drug can cause NMS, including: metoclopramide · prochlorperazine · promethazine. The mechanism is identical — abrupt dopamine blockade in the hypothalamus and striatum. The management is the same: stop the metoclopramide immediately · ICU admission · Dantrolene + bromocriptine + aggressive cooling. Because metoclopramide is widely prescribed for nausea in India (including post-operative, for gastroenteritis, and in pregnancy), awareness of metoclopramide-induced NMS is critically important. Call 040-46324365 immediately.

Q: My brother had NMS 2 months ago. He has been off his antipsychotic since then. He needs to go back on medication for his schizophrenia — is it safe?

Restarting antipsychotic medication after NMS is possible, but it must be done cautiously with specific precautions: (1) Wait at least 2 weeks after full resolution of NMS before any rechallenge · (2) Choose an atypical antipsychotic with lower D2 blocking affinity (clozapine has the lowest risk of NMS recurrence) · (3) Start at the lowest possible dose · (4) Ensure the patient is well hydrated and not in a hot environment at the time of restarting · (5) Monitor temperature, CK, and neurological status closely for the first 2 weeks. The risk of NMS recurrence with rechallenge is approximately 30% if returned to the same drug class too soon, but significantly lower with the precautions above. At KIMS, the psychiatry and neurology teams coordinate the safe reintroduction of antipsychotic therapy in NMS survivors. Call 040-44885000.

Q: How do I tell the difference between NMS and serotonin syndrome? My mother is on both an antidepressant and haloperidol.

This is a critical clinical question. Both NMS and serotonin syndrome cause hyperthermia, altered consciousness, and autonomic instability. The distinctions: NMS: lead-pipe rigidity (the arm moves uniformly stiff throughout its range of motion, like bending a lead bar) · Reduced reflexes · Onset over 24–72 hours · Caused by the haloperidol (dopamine blocker) · Treatment: dantrolene + bromocriptine + stop haloperidol. Serotonin syndrome: tremor + clonus (rhythmic, beating contractions at the ankle, knee, or jaw when the limb is moved passively) · Hyperreflexia · Onset within hours of starting or increasing the serotonergic drug · Caused by the antidepressant (SSRI, SNRI, TCA) · Treatment: cyproheptadine + stop serotonergic agent + benzodiazepines. In a patient on both drugs, both can occur simultaneously. The neurologist at KIMS examines for clonus and lead-pipe rigidity to distinguish the two. Call 040-46324365 urgently.

Neuroleptic Malignant Syndrome (NMS) is a life-threatening idiosyncratic reaction to dopamine-blocking medications — principally antipsychotic drugs (typical and atypical) and antiemetics such as metoclopramide and prochlorperazine. It is characterised by a tetrad of: hyperthermia (core temperature often exceeding 40°C) · extreme generalised muscle rigidity (lead-pipe rigidity) · altered consciousness (ranging from confusion to coma) · autonomic instability (tachycardia, labile blood pressure, diaphoresis, tachypnoea). Without prompt recognition and treatment, NMS has a mortality of 10–20%. With appropriate ICU management, mortality has fallen to 5–10% in specialist centres.

View Our Specialists

NMS is a life-threatening idiosyncratic reaction to dopamine-blocking medications — antipsychotics (typical and atypical) AND antiemetics (metoclopramide, prochlorperazine, promethazine). The mechanism: sudden profound central dopamine D2 receptor blockade in the hypothalamus (thermoregulatory failure) and striatum (extrapyramidal rigidity) produces the defining tetrad: (1) hyperthermia (typically >40°C); (2) lead-pipe muscle rigidity; (3) altered consciousness (confusion to coma); (4) autonomic instability (tachycardia, labile BP, diaphoresis). NMS is not a dose-dependent toxicity — it is an idiosyncratic reaction that can occur at any dose, at any stage of treatment. Serum CK is massively elevated (often >1,000 IU/L, sometimes >100,000 IU/L) from muscle breakdown by the extreme rigidity. Rhabdomyolysis-induced acute kidney injury (AKI) is a major complication. Untreated mortality 10–20%. Gurrera 2011 diagnostic criteria: ≥2 major criteria + dopamine blocker exposure within 72 hours + exclusion of other causes. KEY DIFFERENTIAL: NMS vs serotonin syndrome — distinguished by rigidity vs clonus, hyporeflexia vs hyperreflexia, onset days vs hours, and causative agent (dopamine blocker vs serotonergic).

NMS tetrad and its mechanistic basis: (1) HYPERTHERMIA >40°C: from hypothalamic thermoregulatory failure when dopaminergic input is removed. (2) LEAD-PIPE RIGIDITY: from nigrostriatal dopamine depletion. The rigidity itself generates heat, creating a vicious cycle. (3) ALTERED CONSCIOUSNESS: from diffuse cerebral dysfunction from hyperthermia + autonomic instability. (4) AUTONOMIC INSTABILITY: tachycardia, labile BP, diaphoresis, tachypnoea — from hypothalamic autonomic control failure.
NMS vs serotonin syndrome — the bedside distinction: NMS: LEAD-PIPE rigidity (smooth, plastic resistance throughout range) · HYPOREFLEXIA · ONSET over 24–72 hours · CAUSE: dopamine blocker. SEROTONIN SYNDROME: CLONUS (rhythmic, beating involuntary contractions when joint moved passively) · HYPERREFLEXIA · ONSET within hours · CAUSE: serotonergic agent (SSRI, SNRI, TCA, tramadol, MAOIs). Treatment differs completely: NMS = dantrolene + bromocriptine + stop dopamine blocker · SS = cyproheptadine + stop serotonergic agent + benzodiazepines.
Metoclopramide NMS — the underrecognised cause in India: Metoclopramide (Perinorm, Reglan, Maxolon) is a dopamine D2 receptor antagonist — the same pharmacological mechanism as antipsychotics — and is a recognised cause of NMS. In India, metoclopramide is widely prescribed for nausea (post-operative, gastroenteritis, pregnancy, gastroparesis). NMS from metoclopramide is significantly underrecognised. Metoclopramide is a recognized trigger of NMS; patients taking it who develop fever, rigidity, altered mental status and autonomic instability should be urgently evaluated for NMS and other possible causes.
CK and rhabdomyolysis — severity markers: Serum CK in NMS is massively elevated: typically >1,000 IU/L, often >10,000 IU/L, and in severe cases exceeding 100,000 IU/L. Rhabdomyolysis releases myoglobin into the bloodstream, which precipitates in the renal tubules and causes acute kidney injury (AKI). Management: aggressive IV crystalloid to maintain urine output >200 mL/hour; avoid nephrotoxic drugs; consider early dialysis if AKI is severe. Serial CK every 6–12 hours monitors treatment response.
Calcium channel blockers CONTRAINDICATED with dantrolene: Calcium channel blockers (verapamil, diltiazem, nifedipine) must NOT be used concurrently with dantrolene in the management of either NMS or MH. The combination causes cardiovascular collapse (severe hypotension and heart failure) and dangerous hyperkalaemia. This is a critically important drug interaction that must be communicated to every treating team.
Rechallenge after NMS — when and how: (1) Wait at least 2 weeks after complete NMS resolution; (2) Choose clozapine (lowest dopamine D2 affinity, lowest NMS risk); (3) Start at the lowest possible dose; (4) Ensure adequate hydration; (5) Avoid hot environments; (6) Monitor temperature and CK closely for the first 2 weeks. Recurrence risk with same drug class too soon: approximately 30%.
NMS from levodopa withdrawal: NMS can also occur when dopaminergic medications are suddenly withdrawn in Parkinson's patients — specifically levodopa or amantadine. The mechanism is the same: sudden loss of dopaminergic tone. This is most common when Parkinson's patients are made nil by mouth for surgery or have an acute illness preventing oral intake. Levodopa must be continued or administered via nasogastric tube in every hospitalised Parkinson's patient who cannot take it orally.

Fact	Details
NMS tetrad	Hyperthermia >40°C · Lead-pipe rigidity (uniform plastic) · Altered consciousness · Autonomic instability (tachycardia, labile BP, diaphoresis)
Causative drugs	Haloperidol (most common India) · All typical + atypical antipsychotics · Metoclopramide, prochlorperazine, promethazine (underrecognised) · Levodopa/amantadine WITHDRAWAL
vs Serotonin Syndrome	NMS: lead-pipe rigidity + hyporeflexia + days + dopamine blocker · SS: clonus + hyperreflexia + hours + serotonergic agent · Completely different treatments
CK and rhabdomyolysis	CK often >1,000 IU/L, sometimes >100,000 IU/L · Rhabdomyolysis → AKI · IV crystalloid to maintain urine output >200 mL/hr · Serial CK 6–12 hourly
Treatment	Stop drug immediately · Dantrolene 2.5 mg/kg IV bolus (repeat PRN, max 10 mg/kg) · Bromocriptine 2.5–5 mg TID · Aggressive cooling · IV fluids + ICU monitoring
Contraindication	Calcium channel blockers CONTRAINDICATED with dantrolene · Risk: cardiovascular collapse + hyperkalaemia
Rechallenge	Wait ≥2 weeks · Use clozapine (lowest D2 affinity) · Lowest dose + hydrated + cool environment · ~30% recurrence risk with same class too soon

About This Condition

Neuroleptic Malignant Syndrome at a Glance

Causative drugs

Typical antipsychotics (haloperidol most commonly implicated) · Atypical antipsychotics (olanzapine, risperidone, clozapine, quetiapine — lower but real risk) · Antiemetics: metoclopramide, prochlorperazine, promethazine · Withdrawal of antiparkinsonian agents (levodopa, amantadine) can also precipitate NMS.

NMS tetrad

(1) Hyperthermia (≥38°C, typically >40°C) · (2) Severe generalised rigidity (lead-pipe) · (3) Altered consciousness (confusion to coma) · (4) Autonomic instability (tachycardia, BP lability, diaphoresis, tachypnoea).

Onset

Typically within 1–2 weeks of starting or increasing a dopamine blocker · Can occur at any time · May be precipitated by dehydration, physical exertion, or rapid dose escalation.

Risk factors

Dehydration · High ambient temperature · High-potency typical antipsychotics · Rapid dose escalation · Depot formulations · Physical agitation · Concomitant lithium.

Lab findings

Massively elevated creatine kinase (CK) — often >1,000 IU/L, sometimes >100,000 IU/L (from muscle breakdown) · Leukocytosis · Myoglobinuria · Elevated creatinine (rhabdomyolysis-induced AKI) · Metabolic acidosis.

Key differential

Serotonin syndrome: hyperreflexia + clonus + agitation (vs NMS: lead-pipe rigidity + bradyreflexia) · Onset: hours (SS) vs days (NMS) · Cause: serotonergic agents (SS) vs dopamine blockers (NMS).

Treatment

(1) Stop offending drug · (2) Dantrolene sodium IV · (3) Bromocriptine or amantadine (dopamine agonist) · (4) Aggressive cooling · (5) IV fluids + ICU monitoring · (6) Benzodiazepines for agitation.

India note

Haloperidol most common cause in India · Metoclopramide-induced NMS underrecognised · Summer heat in Hyderabad compounds hyperthermia · Dantrolene: ensure stocked in ICU.

About This Condition

Neuroleptic Malignant Syndrome — The Idiosyncratic Dopamine-Blocker Emergency

NMS is not a predictable dose-dependent toxicity — it is an idiosyncratic reaction that can occur at any dose, at any stage of treatment (though most commonly within the first weeks of starting or dose-escalating a dopamine blocker). The mechanism is a sudden, profound reduction in central dopaminergic activity in the striatum and hypothalamus, producing the thermoregulatory failure, motor rigidity from nigrostriatal dopamine depletion, and autonomic instability from hypothalamic disruption. In India, where antipsychotic use is widespread in the management of schizophrenia, bipolar disorder, and other psychiatric conditions, and where the summer heat of cities like Hyderabad (temperatures exceeding 40°C) can compound medication-induced hyperthermia, NMS represents a particularly important neurological emergency.

Emergency / Consultation

Speak directly with the KIMS neurointensive care team — coordinated emergency identification of NMS, immediate cessation of the offending drug, IV dantrolene and bromocriptine, aggressive cooling, and ICU monitoring for rhabdomyolysis and AKI.

040-44885000Emergency: 040-46324365

Diagnosis at KIMS

Mechanism and Pathophysiology

Central dopamine depletion — the unifying mechanism

Dopamine plays a critical role in temperature regulation (through the hypothalamus), motor control (through the striatum), and autonomic regulation. When dopamine D2 receptors are abruptly and profoundly blocked — as occurs in NMS — three systems fail simultaneously: (1) Hypothalamic thermoregulation fails: the normal dopaminergic input that keeps the hypothalamic thermostat set normally is removed, and the set-point rises unchecked, producing hyperthermia. (2) Nigrostriatal dopamine depletion produces extrapyramidal rigidity: the basal ganglia, deprived of dopamine, produce extreme muscle tone increase and lead-pipe rigidity throughout the body. The rigidity itself generates heat (from uncontrolled muscle contraction), creating a vicious cycle of hyperthermia → more rigidity → more hyperthermia. (3) Hypothalamic autonomic control fails: producing the cardiovascular instability (tachycardia, labile BP), diaphoresis, and respiratory dysfunction.

NMS vs serotonin syndrome — the critical differential

Both NMS and serotonin syndrome (SS) present with hyperthermia, altered consciousness, and autonomic instability — but they are caused by completely opposite neurotransmitter perturbations and have completely different treatments. The key distinction is in the muscle tone and reflexes: NMS: lead-pipe (uniform, plastic) rigidity · Normal or reduced reflexes (hyporeflexia) · Onset over days (24–72 hours) · Caused by dopamine blockade. Serotonin syndrome: tremor + clonus (rhythmic, involuntary muscle contractions provoked by passive movement) · Hyperreflexia · Onset within hours · Caused by excess serotonin (SSRIs + MAOIs, or SSRIs at high dose, or tramadol + SSRI combinations). Treatment differs completely: NMS = dantrolene + bromocriptine + stop dopamine blocker · SS = cyproheptadine (serotonin antagonist) + stop serotonergic agent + benzodiazepines. Misdiagnosis carries severe consequences.

Our Diagnostic Process

Diagnosis at KIMS

NMS is diagnosed at KIMS through a structured four-stage workflow that begins with clinical recognition using the Gurrera 2011 criteria and serum CK as a severity marker, monitors rhabdomyolysis and acute kidney injury with myoglobin, electrolytes, LFTs, and coagulation, uses MRI brain and lumbar puncture to exclude structural and infectious mimics, and applies continuous core temperature monitoring with rectal or oesophageal probes to guide cooling intensity :

Clinical diagnosis — the Gurrera diagnostic criteria

NMS is a clinical diagnosis. The Gurrera (2011) criteria require: at least two major criteria (hyperthermia >38°C, rigidity, elevated CK >4x ULN, or encephalopathy) plus exposure to a dopamine-blocking agent within 72 hours, plus exclusion of other causes. Serum CK is a mandatory test: markedly elevated CK (>1,000 IU/L, sometimes >100,000 IU/L) reflects rhabdomyolysis from the extreme muscle rigidity and is a severity marker. Serial CK monitoring guides treatment intensity.

Rhabdomyolysis and AKI monitoring

CK + renal function (urea, creatinine) + electrolytes + urine myoglobin · Rhabdomyolysis from extreme muscle breakdown can cause acute kidney injury (AKI) via myoglobin-induced tubular toxicity · Target urine output >200 mL/hour with IV crystalloid · Avoid nephrotoxic drugs · Dialysis if severe AKI. LFTs, coagulation (DIC can complicate severe NMS).

MRI brain and LP — to exclude structural and infectious causes

MRI brain: exclude structural lesion (abscess, haemorrhage, tumour) · Lumbar puncture: exclude meningitis/encephalitis (high priority if fever + confusion — though NMS CSF is typically normal). EEG: non-specific slow-wave changes in NMS · Exclude non-convulsive status epilepticus.

Core temperature monitoring — continuous rectal or oesophageal

NMS hyperthermia can progress rapidly and significantly underestimated by axillary or oral thermometers. Core temperature must be measured continuously (rectal or oesophageal probe) to guide cooling intensity. Temperature >41°C is a neurological emergency requiring immediate aggressive cooling.

Treatment

Emergency Management at KIMS

Four-Step NMS Emergency Protocol

Stop Drug, Dantrolene, Bromocriptine, and Supportive ICU Care

Step 1 — Stop the Offending Drug Immediately: The single most important intervention. All dopamine-blocking medications are stopped. If the patient is on depot (long-acting injectable) antipsychotic, the drug cannot be removed but its dosing can be avoided. If NMS is triggered by levodopa withdrawal in a Parkinson's patient, levodopa should be reinstated.

Step 2 — Dantrolene Sodium IV: Dantrolene is a direct-acting muscle relaxant that blocks calcium release from the sarcoplasmic reticulum in skeletal muscle, breaking the cycle of uncontrolled muscle contraction and heat generation. Dose: 1–2.5 mg/kg IV bolus, repeated every 5–10 minutes to effect, maximum 10 mg/kg/day · Then maintenance 1–2 mg/kg IV every 6 hours for 2–3 days · Oral dantrolene 50–200 mg/day to complete a course of 7–10 days. Dantrolene can cause hepatotoxicity with prolonged use — monitor LFTs.

Step 3 — Bromocriptine or Amantadine (Dopaminergic Restoration): Bromocriptine 2.5–5 mg three times daily (via nasogastric tube if needed): a dopamine D2 agonist that partially restores dopaminergic tone in the striatum and hypothalamus. Amantadine 200–400 mg/day: releases dopamine from presynaptic stores. Combination with dantrolene is more effective than either alone. Continue for at least 10 days after resolution (premature discontinuation risks relapse).

Step 4 — Supportive ICU Care: Cooling: Ice packs to axillae + groin · Cooling blanket · IV cold saline · Target temperature <38.5°C. IV fluids: Aggressive crystalloid for rhabdomyolysis and dehydration · Target urine output 1–3 mL/kg/hour. Airway: Intubation if GCS ≤8 or respiratory compromise from chest wall rigidity. Benzodiazepines: For agitation, shivering, and muscle spasm (lorazepam IV). Anticoagulation: Prophylactic LMWH for DVT prevention in immobilised patients.

Related Conditions

Neuroleptic malignant syndrome belongs to the family of autonomic nervous system disorders evaluated and managed at KIMS Neuroscience. Explore related conditions.

Malignant Hyperthermia Multiple System Atrophy

FAQs

Frequently Asked Questions

Call 040-46324365 immediately and bring him to the KIMS emergency department. Do not wait for the psychiatrist. High fever with extreme muscle stiffness in a patient on haloperidol must be urgently evaluated for Neuroleptic Malignant Syndrome and other possible causes — a neurological and medical emergency. While waiting for the ambulance: do not give any additional medications · Keep him cool (fan, cool water on skin, air conditioning) · Give sips of water if he is conscious and can swallow. At KIMS, the emergency team will stop the haloperidol, check serum CK and renal function, start IV dantrolene, begin aggressive cooling, and admit to the ICU. Time from recognition to treatment is the most important factor in survival. Call 040-46324365 now.

Yes — metoclopramide (the commonly used antiemetic Perinorm or Reglan) is a dopamine D2 receptor antagonist and is a recognised though underappreciated cause of NMS. This is one of the most important points about NMS in India — it is not exclusively a reaction to antipsychotic drugs. Any dopamine-blocking drug can cause NMS, including: metoclopramide · prochlorperazine · promethazine. The mechanism is identical — abrupt dopamine blockade in the hypothalamus and striatum. The management is the same: stop the metoclopramide immediately · ICU admission · Dantrolene + bromocriptine + aggressive cooling. Because metoclopramide is widely prescribed for nausea in India (including post-operative, for gastroenteritis, and in pregnancy), awareness of metoclopramide-induced NMS is critically important. Call 040-46324365 immediately.

Restarting antipsychotic medication after NMS is possible, but it must be done cautiously with specific precautions: (1) Wait at least 2 weeks after full resolution of NMS before any rechallenge · (2) Choose an atypical antipsychotic with lower D2 blocking affinity (clozapine has the lowest risk of NMS recurrence) · (3) Start at the lowest possible dose · (4) Ensure the patient is well hydrated and not in a hot environment at the time of restarting · (5) Monitor temperature, CK, and neurological status closely for the first 2 weeks. The risk of NMS recurrence with rechallenge is approximately 30% if returned to the same drug class too soon, but significantly lower with the precautions above. At KIMS, the psychiatry and neurology teams coordinate the safe reintroduction of antipsychotic therapy in NMS survivors. Call 040-44885000.

This is a critical clinical question. Both NMS and serotonin syndrome cause hyperthermia, altered consciousness, and autonomic instability. The distinctions: NMS: lead-pipe rigidity (the arm moves uniformly stiff throughout its range of motion, like bending a lead bar) · Reduced reflexes · Onset over 24–72 hours · Caused by the haloperidol (dopamine blocker) · Treatment: dantrolene + bromocriptine + stop haloperidol. Serotonin syndrome: tremor + clonus (rhythmic, beating contractions at the ankle, knee, or jaw when the limb is moved passively) · Hyperreflexia · Onset within hours of starting or increasing the serotonergic drug · Caused by the antidepressant (SSRI, SNRI, TCA) · Treatment: cyproheptadine + stop serotonergic agent + benzodiazepines. In a patient on both drugs, both can occur simultaneously. The neurologist at KIMS examines for clonus and lead-pipe rigidity to distinguish the two. Call 040-46324365 urgently.

A fever that does not come down. Muscles as rigid as iron. Confusion in a patient on antipsychotics. Neuroleptic Malignant Syndrome is fatal if unrecognised and dramatically survivable if treated immediately.

At KIMS Hyderabad, the neurointensive care team responds to NMS around the clock. Emergency: 040-46324365.

040-44885000

International enquiries: info@kimsneurosciences.com